Emma Hallam

Emma Hallam BSc MSc PGCertNMP is a Macmillan Consultant Radiographer in Post Treatment and Late Effects at Nottingham University Hospitals NHS Trust, and a recognised clinical leader, educator, and researcher in cancer survivorship and the management of the consequences of cancer treatment.

 In 2013, Emma established the award-winning Nottingham Radiotherapy Late Effects Clinic. As the first dedicated service of its kind in the UK, the clinic provides specialist multidisciplinary care for patients experiencing the complex physical and psychological consequences that can arise following radiotherapy treatment.

 Emma's clinical and research interests focus on head and neck cancer survivorship, particularly Radiation-Induced Fibrosis (RIF), dysphagia, lymphoedema, xerostomia, and rehabilitation. She has been instrumental in advancing the clinical application of Photobiomodulation (PBM) therapy for the management of late effects and is committed to translating emerging evidence into safe, effective, patient-centred care.

 Alongside her clinical leadership role, Emma is an Associate Lecturer at Sheffield Hallam University, where she contributes to the education and development of the future cancer workforce. She is also currently undertaking a PhD at Nottingham Trent University, investigating the role of Photobiomodulation in the prevention and treatment of radiation-induced fibrosis following head and neck cancer treatment.

 Emma is passionate about ensuring that people can not only survive cancer but live well beyond diagnosis. She is a strong advocate for moving beyond the simple recognition of late effects towards a future underpinned by robust research, national clinical guidance, service innovation, and equitable access to effective rehabilitation and supportive care.‍ ‍